Ethical Conduct in Clinical Neuromodulation

7:00 - 8:00 AM Saturday, Jan. 14

This session will explore the role that the industry representatives may have in interacting with the patient undergoing neuromodulation therapy. The discussions will focus on ethical conduct in clinical neuromodulation.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Describe the role of device reprogramming and patient interaction by industry representatives.
  • Identify the role of the physician in ensuring confidentiality is maintained for patients with neuromodulation devices.

Exploring Other Intrathecal Medications for Spasticity Management

Bryan Hoelzer, MD

Is Reprogramming by a Non-Health Care Worker Ok From an Ethical Standpoint?

Johnathan H. Goree, MD

Neuromodulation Remote Networking and Digital Storing: Is Cybersecurity a Threat?

Ryan S. D'Souza, MD

Faculty subject to change.

Faculty:

Bryan Hoelzer, MD

Johnathan H. Goree, MD

Ryan S. D'Souza

 

Moderators:

Vwaire Orhurhu, MD

Ryan S. D'Souza, MD